This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Pannu, J.
Right arrow Articles by Sutcliffe, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pannu, J.
Right arrow Articles by Sutcliffe, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2009, p. 3273-3279, Vol. 53, No. 8
0066-4804/09/$08.00+0     doi:10.1128/AAC.00218-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

NB-002, a Novel Nanoemulsion with Broad Antifungal Activity against Dermatophytes, Other Filamentous Fungi, and Candida albicans{triangledown}

J. Pannu,1 A. McCarthy,1 A. Martin,1 T. Hamouda,1 S. Ciotti,1 A. Fothergill,2 and J. Sutcliffe1*

NanoBio Corporation, 2311 Green Road, Suite A, Ann Arbor, Michigan 48105,1 Fungal Testing Laboratory, University of Texas Health Science Center, San Antonio, Texas 782292

Received 17 February 2009/ Returned for modification 15 April 2009/ Accepted 2 May 2009

NB-002 is an oil-in-water emulsion designed for use for the treatment of skin, hair, and nail infections. The activity of NB-002 was compared to the activities of the available antifungal drugs against the major dermatophytes responsible for cutaneous infections, Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, and Microsporum spp., as well as 12 other genera of filamentous fungi. NB-002 consistently displayed fungicidal activity against all dermatophytes. The comparator compounds were either fungistatic or fungicidal, and for some strain-drug combinations, tolerance was observed. Assessment of the development of spontaneous resistance to NB-002 in different dermatophyte species yielded few stably resistant mutants. For filamentous nondermatophyte fungi, the MIC range varied from 0.06 to 0.5 µg/ml for Alternaria spp. to 2 to 8 µg/ml for Paecilomyes spp. NB-002 had activity against both azole-susceptible and -resistant Candida albicans yeast isolates, with MIC90s of 2 µg/ml, respectively, and minimum fungicidal concentrations at which 90% of isolates are inhibited of 4 and 8 µg/ml, respectively. The kinetics of the fungicidal activity of NB-002 against T. rubrum isolates were compared to those of the other antifungal drugs. NB-002 killed both mycelia and microconidia even when the fungal forms were dormant or not actively growing. Electron micrographs of mycelia and spores treated with NB-002 showed the significant disruption of the fungal structure. The in vitro broad coverage of NB-002 against filamentous fungi, dermatophytes, and C. albicans, as well as its rapid fungicidal activity, warrants further investigations to ascertain if NB-002 would be useful for the treatment of cutaneous mycoses.

* Corresponding author. Present address: SVP, Research, Tetraphase Pharmaceuticals, Inc., 480 Arsenal St., Suite 110, Watertown, MA 02472. Phone: (617) 715-3595. Fax: (617) 926-3557. E-mail: jsutcliffe{at}tphase.com

{triangledown} Published ahead of print on 11 May 2009.

Antimicrobial Agents and Chemotherapy, August 2009, p. 3273-3279, Vol. 53, No. 8
0066-4804/09/$08.00+0     doi:10.1128/AAC.00218-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»